Clinical Trials Search Results

1 - 10 of 37 Results

A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)

This study will evaluate the efficacy of VX-445 in triple combination (TC) with tezacaftor (TEZ) and ivacaftor (IVA) in subjects with cystic...

A Study of AeroVanc for the Treatment of MRSA Infection in CF Patients

This study is a multi-center, randomized phase III study to evaluate the clinical effectiveness of AeroVanc in persistent MRSA in patients with...

A Study of VX-445 Combination Therapy in CF Subjects Homozygous for F508del (F/F)

This study will evaluate the efficacy of VX-445 in triple combination (TC) with tezacaftor (TEZ) and ivacaftor (IVA) in subjects with cystic...

Acute Lymphoblastic Leukemia - A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia

This is a nonrandomized study of ruxolitinib in combination with a standard multi-agent chemotherapy regimen for the treatment of B-cell acute...

Acute Lymphoblastic Leukemia - Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Studies how well blinatumomab works compared with standard combination chemotherapy.
Accepting Participants

Acute Lymphoblastic Leukemia - Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia...

Acute Lymphoblastic Leukemia - Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia.
Accepting Participants

Acute Myeloid Leukemia - Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

Studies response-based chemotherapy in treating newly diagnosed acute myeloid leukemia.
Accepting Participants
1 - 10 of 37 Results